A new contract for integrated care
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explain how the new GP contract will shape local joined-up systems
Search Results for: Steve How, Paul Midgley
How can pharma support NHS transformation?
Steve How, Paul Midgley and Oli Hudson of the Wilmington Consulting Team find some answers in recently updated NHS England guidance
Read More
The Plan in action
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the seismic changes that have been occurring in the NHS since the Long Term Plan was published
Read More
Integrated care agenda stimulates seismic change in 2018
The NHS has been taking an increasingly joined-up approach to care during 2018, significantly altering how it works with pharma
Read More
Biosimilar adalimumab: a landmark for NHS medicines optimisation
The implications of adalimumab’s European patent expiry
Read More- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
- Study finds mechanical changes in tumour tissue offer new insights for cancer research
- Cambridge study finds AI more accurately assesses eye problems compared to doctors
